Thus, the VEGFA-resistant vessel barrier phenotype in the Vegfr2Y949F/Y949F tumours correlated with an enhanced drug effect at D12, probably due to the lower oedema, and hence a lower interstitial tumour pressure, at this stage. This evidence concerns the gene VEGFA and neoplasm.